メインコンテンツにスキップ
検索
製品紹介資料

Expedited Pharmacometrics Regulatory Submissions

Skip to PDF content

Connect with Certara

Connect with a Certara pharmacometrics consultant to discuss your regulatory objectives and map out an accelerated PMx plan.

詳細を表示

関連コンテンツ

How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer
How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal CancerCase Study

How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer

ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development
ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug DevelopmentBlog

ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development

Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)
Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)Guide

Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)

Powered by Translations.com GlobalLink Web Software